Rotavirus: Genetics, pathogenesis and vaccine advances

Area of Science:

• Virology and Immunology
• Global Public Health
• Vaccinology

Background:

• Rotavirus (RV) is a leading cause of infant and childhood gastroenteritis, responsible for substantial morbidity and mortality, particularly in developing countries.
• Existing rotavirus vaccines (RV5, RV1) show reduced efficacy in Africa and Asia, highlighting a need for improved global strategies.
• The World Health Organization recommends rotavirus vaccination, with 86 countries now including it in national immunization programs.

Purpose of the Study:

• To review current insights into rotavirus structure, classification, and epidemiology.
• To summarize the global status of rotavirus vaccination.
• To discuss the status of rotavirus research and vaccine policy in Pakistan.

Main Methods:

• Comprehensive literature review of previous and recent studies on rotavirus.
• Analysis of global epidemiological data and vaccine efficacy studies.
• Examination of rotavirus genotype prevalence and genetic diversity.

Main Results:

• Predominant rotavirus genotypes globally include G1P[8], G2P[4], G3P[8], G4P[8], and G9P[8], with emerging genotypes like G12P[6] and G12P[8].
• Rotavirus's segmented genome drives significant genetic diversity, potentially impacting current vaccine effectiveness.
• Vaccine effectiveness varies geographically, necessitating tailored approaches.

Conclusions:

• A global rotavirus surveillance program is essential to monitor genotype prevalence and antigenic variability.
• Continuous research and strategic planning are vital for future rotavirus vaccine development and policy.
• Understanding regional variations in rotavirus epidemiology and vaccine response is key to controlling the disease burden.